Clinical Trial Update: A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso [Phase 1]

View source ↗

Summary

Phase Ib trial of MSP 3 LSP for malaria in 1-2 year-old children in Burkina Faso. The entry does not provide results or a current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MSP 3 LSP

Snippet

Sponsor: African Malaria Network Trust | Conditions: Malaria | Phase 1 | Status: UNKNOWN